Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)

Christina Canavati; Ahmad Siam; Sapir Labes; Nirit Trabelsi; Eshcar Regev; Elchanan Parnasa; Barhoum Barhoum; Nur Magadle; Ofer Perzon; Maya Braun; Hagar Mor-Shaked; Ora Schueler-Furman; Yuval Tabach; Dror Mevorach

doi:10.1161/circulationaha.123.064884

Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)

Christina Canavati
, Ahmad Siam
, Sapir Labes
, Nirit Trabelsi
, Eshcar Regev
, Elchanan Parnasa
, Barhoum Barhoum
, Nur Magadle
, Ofer Perzon
, Maya Braun
, Hagar Mor-Shaked
, Ora Schueler-Furman
, Yuval Tabach
, Dror Mevorach^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	270-273
Number of pages	4
Journal	Circulation
Volume	149
Issue number	3
DOIs	https://doi.org/10.1161/circulationaha.123.064884
State	Published - 16 Jan 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1161/circulationaha.123.064884

Cite this

Canavati, C., Siam, A., Labes, S., Trabelsi, N., Regev, E., Parnasa, E., Barhoum, B., Magadle, N., Perzon, O., Braun, M., Mor-Shaked, H., Schueler-Furman, O., Tabach, Y., & Mevorach, D. (2024). Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19). Circulation, 149(3), 270-273. https://doi.org/10.1161/circulationaha.123.064884

@article{70ee002f1ff54a3298af44c6db7c3956,

title = "Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)",

author = "Christina Canavati and Ahmad Siam and Sapir Labes and Nirit Trabelsi and Eshcar Regev and Elchanan Parnasa and Barhoum Barhoum and Nur Magadle and Ofer Perzon and Maya Braun and Hagar Mor-Shaked and Ora Schueler-Furman and Yuval Tabach and Dror Mevorach",

year = "2024",

month = jan,

day = "16",

doi = "10.1161/circulationaha.123.064884",

language = "אנגלית",

volume = "149",

pages = "270--273",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

Canavati, C, Siam, A, Labes, S, Trabelsi, N, Regev, E, Parnasa, E, Barhoum, B, Magadle, N, Perzon, O, Braun, M, Mor-Shaked, H, Schueler-Furman, O , Tabach, Y & Mevorach, D 2024, 'Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)', Circulation, vol. 149, no. 3, pp. 270-273. https://doi.org/10.1161/circulationaha.123.064884

Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19). / Canavati, Christina; Siam, Ahmad; Labes, Sapir et al.
In: Circulation, Vol. 149, No. 3, 16.01.2024, p. 270-273.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)

AU - Canavati, Christina

AU - Siam, Ahmad

AU - Labes, Sapir

AU - Trabelsi, Nirit

AU - Regev, Eshcar

AU - Parnasa, Elchanan

AU - Barhoum, Barhoum

AU - Magadle, Nur

AU - Perzon, Ofer

AU - Braun, Maya

AU - Mor-Shaked, Hagar

AU - Schueler-Furman, Ora

AU - Tabach, Yuval

AU - Mevorach, Dror

PY - 2024/1/16

Y1 - 2024/1/16

UR - https://www.scopus.com/pages/publications/85182272674

U2 - 10.1161/circulationaha.123.064884

DO - 10.1161/circulationaha.123.064884

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 38227712

AN - SCOPUS:85182272674

SN - 0009-7322

VL - 149

SP - 270

EP - 273

JO - Circulation

JF - Circulation

IS - 3

ER -

Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)

UN SDGs

Access to Document

Other files and links

Cite this